The prognostic value of adhesion molecule CD44v6 in women with primary breast carcinoma: a clinicopathologic study

CD44v6 expression was correlated with tumour size, metastases of axillary nodes, pTNM stage, and 5-year survival; however, multivariate analysis revealed that CD44v6 expression failed to be an independent predictor of patient prognosis.